返回 Agenda
Session Chair(s)
Chris Huang
CEO
Pharmacons Tech CO.,LTD, China
Speaker(s)
A Formal Two-Way Communication Meeting with CDE on IND of a Novel Anti-Cancer Drug Using Innovative Development Strategy
Hua MU, MD, PHD
WuXi AppTec, China
Senior Vice President ,Global Head of Product Development Service & Partnership
Effective CDE Consultation Meeting
Mary Sun
Pfizer Investment Co., Ltd, China
Regulatory Affairs Manager
New IND Process for the First in Class Drug CTA Approval at China CDE
Li CHEN
Hua Medicine (Shanghai) Ltd., China
CEO
Topic TBD
Representative Invited
CDE, Taiwan